The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
High-risk MSI-H stage II colon cancer: Treatment patterns and outcomes.
 
Patrick Fleming
No Relationships to Disclose
 
Chunxia Chen
No Relationships to Disclose
 
Dirk F. Moore
No Relationships to Disclose
 
Howard S. Hochster
Stock and Other Ownership Interests - Compass Therapeutics; Processa Pharmaceuticals
Consulting or Advisory Role - Bayer; Genentech; Merck
Speakers' Bureau - Natera
 
Salma K. Jabbour
Consulting or Advisory Role - IMX Medical Reviewer; Merck Sharp & Dohme; Syntactx
Research Funding - Merck Sharp & Dohme (Inst); NCI (Inst)
 
Lyudmyla Derby Berim
No Relationships to Disclose
 
Kristen Renee Spencer
Consulting or Advisory Role - Caris Life Sciences; Helsinn Therapeutics; Lynx Group; QED Therapeutics
 
Pat Gulhati
No Relationships to Disclose
 
Kristen Donohue
No Relationships to Disclose
 
Nell Maloney Patel
No Relationships to Disclose
 
Patrick M Boland
Consulting or Advisory Role - Bayer; Guardant Health; Merck; Pfizer
Research Funding - Amgen (Inst); Macrogenics (Inst); Merck (Inst); Processa Pharmaceuticals (Inst)